Emerik Osterlund

Uppsala Universitet Farmaceutiska fakulteten

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Cancer Biology Cancer Biology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (9)

Lucy Mathot

Uppsala University

SWEDEN

View details

Pirjo Nummela

University of Helsinki

FINLAND

View details

Tobias Sjöblom

Professor at Uppsala University

Uppsala University

SWEDEN

View details

Malin Ljunggren

Karolinska Institutet

SWEDEN

View details

Caroline Nordenvall

Karolinska Institutet

SWEDEN

View details

Pia Osterlund

Karolinska University Hospital

SWEDEN

View details

Teijo Kuopio

FINLAND

View details

Anna Martling

Karolinska Institutet

SWEDEN

View details

Artur Mezheyeuski

Uppsala University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Emerik Osterlund

Research Interests

Explore related searches

Contact this professor

Articles (10)

Evaluation of Bridge Capture technology for mutation profiling in liquid biopsies of metastatic colorectal cancer patients

Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer

Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)

Prognostic genome and transcriptome signatures in colorectal cancers.

Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts

Sex differences in metastatic surgery following diagnosis of synchronous metastatic colorectal cancer

Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study

Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancer

Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study

Collaborators (9)

Lucy Mathot

Pirjo Nummela

Tobias Sjöblom

Malin Ljunggren

Caroline Nordenvall

Pia Osterlund

Teijo Kuopio

Anna Martling

Artur Mezheyeuski

Make your next move.